CCT-217

N/A

Report date: 2025/09/04 15:44:10
NME

Base Information

Drug NameCCT-217
Drug Alias NameCCT-217
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCannabinoid CB1 receptor antagonistsZinc Finger Protein 423 inhibitors
TargetsCannabinoid CB1 receptorZinc Finger Protein 423
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCanary Global Inc
China Registration ClassN/A

Develop Information

Active CompaniesCanary Global Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A